133.02
price down icon0.54%   -0.72
after-market アフターアワーズ: 133.30 0.28 +0.21%
loading
前日終値:
$133.74
開ける:
$134.085
24時間の取引高:
4.82M
Relative Volume:
0.78
時価総額:
$231.52B
収益:
$43.11B
当期純損益:
$13.94B
株価収益率:
16.64
EPS:
7.9963
ネットキャッシュフロー:
$6.78B
1週間 パフォーマンス:
-0.69%
1か月 パフォーマンス:
+0.06%
6か月 パフォーマンス:
+6.54%
1年 パフォーマンス:
+17.34%
1日の値動き範囲:
Value
$131.93
$134.09
1週間の範囲:
Value
$129.08
$135.45
52週間の値動き範囲:
Value
$110.86
$140.84

Abbott Laboratories Stock (ABT) Company Profile

Name
名前
Abbott Laboratories
Name
セクター
Healthcare (1138)
Name
電話
(224) 667-6100
Name
住所
100 ABBOTT PARK ROAD, ABBOTT PARK, IL
Name
職員
114,000
Name
Twitter
@AbbottNews
Name
次回の収益日
2025-07-17
Name
最新のSEC提出書
Name
ABT's Discussions on Twitter

ABT を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Medical Devices icon
ABT
Abbott Laboratories
133.02 232.77B 43.11B 13.94B 6.78B 7.9963
Medical Devices icon
BSX
Boston Scientific Corp
95.90 143.29B 18.49B 2.50B 3.49B 1.6801
Medical Devices icon
SYK
Stryker Corp
369.24 140.03B 23.82B 2.92B 4.02B 7.5574
Medical Devices icon
MDT
Medtronic Plc
98.33 126.25B 34.20B 4.69B 5.30B 3.6218
Medical Devices icon
EW
Edwards Lifesciences Corp
76.72 44.95B 5.69B 1.41B 577.90M 6.9828

Abbott Laboratories Stock (ABT) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-07-18 アップグレード Jefferies Hold → Buy
2025-06-16 開始されました Leerink Partners Market Perform
2024-10-08 開始されました Oppenheimer Outperform
2024-09-19 開始されました Piper Sandler Overweight
2024-07-30 ダウングレード Edward Jones Buy → Hold
2024-05-30 開始されました Goldman Buy
2023-07-21 アップグレード Wolfe Research Underperform → Peer Perform
2023-05-30 ダウングレード Morgan Stanley Overweight → Equal-Weight
2023-04-20 繰り返されました Barclays Overweight
2023-04-20 繰り返されました Bernstein Outperform
2023-04-20 繰り返されました JP Morgan Overweight
2023-04-20 繰り返されました Raymond James Outperform
2023-04-20 繰り返されました UBS Buy
2023-04-20 繰り返されました Wolfe Research Underperform
2023-03-29 開始されました UBS Buy
2022-10-26 開始されました Mizuho Neutral
2022-10-18 開始されました Barclays Overweight
2022-10-12 開始されました Jefferies Hold
2022-07-06 開始されました Wolfe Research Underperform
2022-03-02 再開されました BofA Securities Buy
2022-01-27 繰り返されました Credit Suisse Outperform
2022-01-27 繰り返されました Morgan Stanley Overweight
2022-01-27 繰り返されました Raymond James Outperform
2022-01-27 繰り返されました UBS Buy
2021-12-10 開始されました RBC Capital Mkts Outperform
2021-10-27 アップグレード Atlantic Equities Neutral → Overweight
2021-10-14 開始されました Redburn Neutral
2021-05-25 開始されました Barclays Overweight
2021-04-15 開始されました Atlantic Equities Neutral
2021-01-28 アップグレード BTIG Research Neutral → Buy
2020-09-11 開始されました Wolfe Research Outperform
2020-06-01 ダウングレード Goldman Neutral → Sell
2020-03-05 開始されました Citigroup Buy
2020-02-13 開始されました Goldman Neutral
2020-02-06 再開されました BTIG Research Neutral
2020-01-02 ダウングレード Guggenheim Buy → Neutral
2019-06-13 繰り返されました BofA/Merrill Buy
2019-02-07 繰り返されました BofA/Merrill Buy
2019-01-02 ダウングレード Citigroup Neutral → Sell
2018-11-30 アップグレード Goldman Neutral → Buy
2018-10-16 開始されました Barclays Overweight
2018-06-27 開始されました Bernstein Outperform
2018-01-30 繰り返されました Citigroup Neutral
2018-01-25 繰り返されました Stifel Buy
2018-01-25 アップグレード William Blair Mkt Perform → Outperform
2018-01-03 開始されました Evercore ISI Outperform
2018-01-02 アップグレード JP Morgan Neutral → Overweight
2018-01-02 アップグレード Morgan Stanley Equal-Weight → Overweight
2017-10-19 繰り返されました RBC Capital Mkts Outperform
2017-10-19 繰り返されました Stifel Buy
すべてを表示

Abbott Laboratories (ABT) 最新ニュース

pulisher
Oct 07, 2025

Evercore ISI Adjusts Abbott Laboratories Price Target to $144 From $140, Maintains Outperform Rating - MarketScreener

Oct 07, 2025
pulisher
Oct 07, 2025

Abbott Laboratories' (NYSE:ABT) Returns On Capital Are Heading Higher - Yahoo

Oct 07, 2025
pulisher
Oct 06, 2025

The Zacks Analyst Blog Highlights Advanced Micro Devices, Abbott Laboratories and Micron Technology - Zacks Investment Research

Oct 06, 2025
pulisher
Oct 06, 2025

Thyroid Cancer Diagnostics Market Size to Surge USD 5.22 Billion at 5.34% CAGR by 2034 - GlobeNewswire Inc.

Oct 06, 2025
pulisher
Oct 05, 2025

Precision Trading with Abbott Laboratories (ABT) Risk Zones - news.stocktradersdaily.com

Oct 05, 2025
pulisher
Oct 05, 2025

Is Abbott Laboratories (ABL) stock positioned for secular growthPortfolio Update Summary & Low Drawdown Trading Strategies - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

What candlestick patterns are forming on Abbott LaboratoriesMarket Risk Analysis & Risk Controlled Swing Alerts - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

Top Stock Reports for AMD, Abbott & Micron Technology - The Globe and Mail

Oct 03, 2025
pulisher
Oct 03, 2025

Abbott (ABT) Laps the Stock Market: Here's Why - Yahoo Finance

Oct 03, 2025
pulisher
Oct 03, 2025

How Abbott Laboratories (ABT) Affects Rotational Strategy Timing - news.stocktradersdaily.com

Oct 03, 2025
pulisher
Oct 03, 2025

Abbott Laboratories (ABT): Exploring Valuation as Steady Gains Draw Investor Interest in 2024 - simplywall.st

Oct 03, 2025
pulisher
Oct 03, 2025

Abbott (ABT) Is Considered a Good Investment by Brokers: Is That True? - Yahoo

Oct 03, 2025
pulisher
Oct 03, 2025

‘Few missions more meaningful than improving global health,’ says HR expert - Silicon Republic

Oct 03, 2025
pulisher
Oct 02, 2025

Why analysts recommend Abbott Laboratories (ABL) stockJuly 2025 Breakouts & Long-Term Safe Investment Ideas - newser.com

Oct 02, 2025
pulisher
Oct 02, 2025

Ready To Pass On Abbott Laboratories (NYSE:ABT)? Think Again - 富途牛牛

Oct 02, 2025
pulisher
Oct 02, 2025

Goldman Sachs Maintains Abbott Laboratories(ABT.US) With Buy Rating - 富途牛牛

Oct 02, 2025
pulisher
Oct 02, 2025

Abbott Laboratories (ABT) Maintains Strong MedTech Growth Outlook - Insider Monkey

Oct 02, 2025
pulisher
Oct 02, 2025

2 Profitable Stocks to Consider Right Now and 1 We Find Risky - FinancialContent

Oct 02, 2025
pulisher
Oct 01, 2025

Abbott Laboratories Q3 Earnings Preview: Profit boost expected - MSN

Oct 01, 2025
pulisher
Oct 01, 2025

Abbott Gains Diabetes Tech Expansion Opportunity Following Earnings Beat and Insider Sale - MSN

Oct 01, 2025
pulisher
Oct 01, 2025

Europe Clinical Nutrition Market to hit US$ 36.63 Billion by 2033 - openPR.com

Oct 01, 2025
pulisher
Oct 01, 2025

Will Abbott Laboratories (Common Stock) (ABL0) stock attract long term capital inflowsJuly 2025 PreEarnings & Low Risk High Reward Ideas - newser.com

Oct 01, 2025
pulisher
Oct 01, 2025

Goldman Sachs Adjusts Price Target on Abbott Laboratories to $157 From $153, Maintains Buy Rating - MarketScreener

Oct 01, 2025
pulisher
Oct 01, 2025

Abbott (ABT) Gains Attention with Inclusion in Goldman Sachs Con - GuruFocus

Oct 01, 2025
pulisher
Sep 30, 2025

Will Abbott Laboratories (ABL) stock return to pre crash levelsJuly 2025 Highlights & Consistent Growth Stock Picks - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Abbott wins Health Canada approval for Esprit drug-eluting, dissolving scaffold - MassDevice

Sep 30, 2025
pulisher
Sep 30, 2025

Union Bancaire Privee UBP SA Sells 30,201 Shares of Abbott Laboratories $ABT - MarketBeat

Sep 30, 2025
pulisher
Sep 30, 2025

Abbott Laboratories $ABT is Paradiem LLC's 5th Largest Position - MarketBeat

Sep 30, 2025
pulisher
Sep 30, 2025

Synlait to sell North Island assets to Abbott for $178m - FoodBev Media

Sep 30, 2025
pulisher
Sep 30, 2025

Health Canada authorises Abbott’s Esprit BTK system for CLTI treatment - Medical Device Network

Sep 30, 2025
pulisher
Sep 30, 2025

HB Wealth Management LLC Cuts Position in Abbott Laboratories $ABT - MarketBeat

Sep 30, 2025
pulisher
Sep 30, 2025

Abbott Laboratories $ABT Shares Bought by Janney Montgomery Scott LLC - MarketBeat

Sep 30, 2025
pulisher
Sep 30, 2025

How buyback programs support Abbott Laboratories stockMarket Risk Summary & Long-Term Capital Growth Ideas - newser.com

Sep 30, 2025
pulisher
Sep 29, 2025

How Abbott Laboratories stock responds to policy changesJuly 2025 Market Mood & High Yield Stock Recommendations - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Synlait Milk agrees North Island asset sale to Abbott Laboratories - Global Food Industry News

Sep 29, 2025
pulisher
Sep 29, 2025

Strategies to average down on Abbott LaboratoriesRecession Risk & AI Based Buy and Sell Signals - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Abbott Laboratories (ABT): A Healthcare Leader Offering Dividend Value and Growth - MSN

Sep 29, 2025
pulisher
Sep 29, 2025

Can swing trading help recover from Abbott Laboratories lossesMarket Weekly Review & Target Return Focused Picks - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It - sharewise.com

Sep 29, 2025
pulisher
Sep 29, 2025

Detecting support and resistance levels for Abbott LaboratoriesMarket Activity Recap & Weekly Sector Rotation Insights - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

NZ's Synlait cuts annual loss, inks asset sale deal; shares surge - Reuters

Sep 29, 2025
pulisher
Sep 29, 2025

Smith Chas P & Associates PA Cpas Sells 2,167 Shares of Abbott Laboratories $ABT - MarketBeat

Sep 29, 2025
pulisher
Sep 29, 2025

GC Wealth Management RIA LLC Grows Position in Abbott Laboratories $ABT - MarketBeat

Sep 29, 2025
pulisher
Sep 29, 2025

Klein Pavlis & Peasley Financial Inc. Acquires Shares of 17,000 Abbott Laboratories $ABT - MarketBeat

Sep 29, 2025
pulisher
Sep 29, 2025

What to Expect From Abbott Laboratories' Next Quarterly Earnings Report - Yahoo Finance

Sep 29, 2025
pulisher
Sep 29, 2025

Moody Lynn & Lieberson LLC Sells 12,285 Shares of Abbott Laboratories $ABT - MarketBeat

Sep 29, 2025
pulisher
Sep 29, 2025

Abbott Laboratories $ABT Shares Sold by Fort Washington Investment Advisors Inc. OH - MarketBeat

Sep 29, 2025
pulisher
Sep 29, 2025

Can volume confirm reversal in Abbott Laboratories2025 Fundamental Recap & Real-Time Market Sentiment Alerts - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

China’s Bright Dairy to Sell New Zealand Assets to Abbott for USD170 Million - 一财全球Yicai Global

Sep 29, 2025
pulisher
Sep 28, 2025

Synlait Milk reports full-year loss ahead of asset sale - RNZ

Sep 28, 2025
pulisher
Sep 28, 2025

Synlait sells Pōkeno site for $307m, manufacturing woes batter bottom line - ThePost.co.nz

Sep 28, 2025

Abbott Laboratories (ABT) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
medical_devices BSX
$95.90
price down icon 0.83%
medical_devices SYK
$369.24
price up icon 0.81%
medical_devices MDT
$98.33
price down icon 0.10%
medical_devices EW
$76.72
price up icon 0.21%
$74.49
price down icon 2.51%
大文字化:     |  ボリューム (24 時間):